Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study. Falchi L, Ma H, Klein S, Lue JK, et al. Blood 2021;137:2161-2170.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Falchi L, Ma H, Klein S, Lue JK, et al. Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study. Blood 2021;137:2161-2170.
PMID: 33171487